Board of Directors

The Pulmonary Fibrosis Foundation (PFF) is proud to have a committed board of directors to help guide the activities that support our important mission.

Members of the board are actively involved in the PFF’s activities and participate in fundraising, promoting awareness, and advocating for the pulmonary fibrosis community. 

The Foundation seeks qualified candidates to join its board of directors. The PFF’s directors lay the groundwork for the Foundation’s strategic vision and contribute significantly to resource development. A central focus of the board of the directors is fundraising.


michael c. henderson


Mike Henderson was elected Chairman of the Board of Directors in June 2014 after serving as Vice Chairman since February 2013. Mike is a founder and served as Chairman of Albina Community Bank from 1995 until he retired at the end of 2009. He currently serves on the board of OrePac Building Products and Prolifiq Software. He was President of PacifiCorp Holdings, Inc which held interests in energy, telecommunications and financial services. He has served as CEO of Vermont Castings, Pinemeadow Group, Prolifiq Software and Crescent Foods, Inc. He was a partner and CPA with Deloitte Haskins & Sells during a seventeen year career there. Mike also served on the board of three public companies; Longview Fibre, Pacific Telecom and Comdial. Mike was diagnosed with idiopathic pulmonary fibrosis in 2004 and received a double lung transplant in 2006. He is a facilitator of Pulmonary Fibrosis and Lung Transplant Support Groups in Seattle and Portland.

kathleen o. lindell, phd, rn


Kathleen Oare Lindell, PhD, RN, serves as the Executive Director for the SUPPORT Program at the University of Pittsburgh Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease at UPMC in Pittsburgh, PA.

Dr. Lindell is a graduate of the St. Francis Hospital School of Nursing where she received her Diploma in Nursing. She received her bachelor’s, master’s, and doctoral degrees in nursing from the University of Pittsburgh School of Nursing. Her early nursing career began as a critical care nurse in the Medical ICU and Emergency Department at St. Francis Hospital, faculty in St. Francis Nursing School, and later as Nurse Manager of the St. Francis Emergency Department. After obtaining her Master’s Degree in Nursing with a pulmonary nursing focus, she was the clinical nurse specialist at the PENN Lung Center at the University of Pennsylvania Medical Center. She developed the PENN Quit Smoking Program while at PENN Lung Center, becoming the tobacco cessation program for the University of Pennsylvania Health System. In 2000, Kathy returned to the University of Pittsburgh to be Clinical Nurse Specialist and Nursing Manager for the newly developed Simmons Center. Kathy is active within the American Thoracic Society, currently serving on the Planning Committee for ATS. Previously she served on the Board of Directors, Chair of the Nursing Assembly, and as the Inaugural Chair of the Patient and Family Education Committee. Kathy is Adjunct Assistant Professor of Acute & Tertiary Care, School of Nursing, University of Pittsburgh. She also serves on the Pulmonary Fibrosis Foundation Medical Advisory Board.



David McNinch is an executive in the biopharma industry with extensive experience in orphan diseases. Over his 20 plus year career he has worked with a number of large and small companies including AstraZeneca, Novartis, Genentech, and InterMune. Recently, he built and lead the organization that commercialized Esbriet (pirfenidone) in the US. After Genentech acquired InterMune, David supported the integration and left to pursue other opportunities including continuing to support patients with pulmonary fibrosis through his work with the PFF. David has worked on the development and commercialization of drugs for orphan diseases including Huntington's disease, Parkinson's disease, acromegaly, and cystic fibrosis. He served on the Board of Trustees for the Huntington's Disease Society of America from 1999 - 2006. David is a native South Carolinian and graduate of the Darla Moore School of Business at the University of South Carolina.

dave steffy


David Steffy is the founder or co-founder of many health care service companies–including Community Health Systems, Odyssey HealthCare, and Intensiva–and as a serial entrepreneur has been a founding co-investor helping other entrepreneurs. He began his healthcare career at The Ohio State University Medical Center working in the business office and rising through the ranks to become Director of Hospital Administration. Later, as the Regional Vice President of Hospital Affiliates he managed 15 hospitals and went on to help form Republic Health, an owner and operator of hospitals. His family has been deeply impacted by IPF, losing his father, brother, and uncle to the disease. David is the sponsor of the Dave Steffy Stem Cell Research Fund for IPF at UCLA that has funded the study, "Modeling IPF Using Induced Pluripotent Stem Cells." David has a Masters of Health Administration from the University of Southern California and a BA from The Ohio State University. He is an honorary graduate of the Hospital Administration Program at Ohio State.

terence f. hales


Terence Hales is a corporate real estate executive based in New York City. He has over 18 years of industry experience and has worked for a number of global Fortune 100 companies including Time Warner, Bear Stearns, Lehman Brothers, CBS Corporation, and Pfizer Inc. In his previous roles he was responsible for real estate strategy, transaction management, and cost efficiency. Mr. Hales is currently the Director of Global Real Estate for Zoetis Inc., the former Pfizer Animal Health Division. Mr. Hales is the founder of the NYC Run-Walk-Hike for Pulmonary Fibrosis, which has raised more than $400,000 toward PF research and patient services. Mr. Hales’s father was diagnosed with PF and subsequently underwent a successful double-lung transplant in 2007. Mr. Hales was previously a board member of the Coalition for Pulmonary Fibrosis, where his work included lobbying members of congress to support research funding for pulmonary fibrosis. Mr. Hales has a Bachelor of Science in Finance and a Masters of Business Administration from Fordham University.

laurie L. CHandler, CFP®

Laurie is a partner at Vigilant Capital, LLC. From 2002 through early 2013, she served clients as both a relationship manager and wealth planner. Prior to joining Vigilant, Laurie was a senior vice president in the private clients group of Fleet Boston Financial for 18 years. Laurie earned her MBA from Southern New Hampshire University, is a Certified Financial Planner™ and a graduate of the Cannon Financial Institute for Trust, Estate, and Financial Planning. In addition to her role with the PFF, Laurie serves as the co-chair of the Patient Family Advisory Council of Portsmouth Regional Hospital. Previously, she served as a board trustee of Southern New Hampshire University, a board member of the Northern New England Financial Planning Association, and as a chair of the Estate Planning Council of New Hampshire. She was also a founding member and chair of the Women’s Business Center, a chair and advisory board member of Families First of the Greater (NH) Seacoast, a chair and treasurer of the New Hampshire Commission on the Status of Women, and a trustee of the Crotched Mountain Foundation. Laurie is a graduate of the 2006 Leadership NH program. In 2002, Laurie was honored with the Small Business Administration’s New Hampshire Women in Business Advocate of the Year Award. 

Colleen Attwell

Colleen Attwell is a Senior Director for the Creating IT Futures Foundation, focusing on workforce development programs in the IT sector. She is also the foundation’s member representative to the Clinton Global Initiative. Her twenty-plus years of experience working in the nonprofit sector began with the American Medical Association and City of Hope. She subsequently worked as the State Director of Development for the March of Dimes Illinois Chapter and as National Director of Development for Prevent Blindness America. Her experience includes fundraising, event planning, volunteer and board management, and program development. In addition, she has volunteered and freelanced in the Chicago sports industry for many years, including work with the Chicago Bears, Chicago Blackhawks, Chicago Fire, and Comcast SportsNet Sports Awards. She holds a BA in Communications from Michigan State University and a graduate certificate in nonprofit management from North Park University. She is a member of the Association of Fundraising Professionals. Colleen’s family has been deeply affected by pulmonary fibrosis as both her father and father-in-law passed away from the disease.


George Eliades is a partner in Bain’s health care practice, based in San Francisco.  He has nearly 15 years of consulting experience. At Bain & Company, Mr. Eliades' recent work focuses on biotech and pharmaceuticals. His work spans commercial and development, and multiple therapeutic areas, with deep expertise in oncology, neurology, endocrinology, ophthalmology, respiratory and several other specialty categories. Mr. Eliades' nonprofit work has included support for the merger integration of CHI and BayBio into the California Life Sciences Association. He has also led work with the American Society of Retina Specialists, focusing on helping the ASRS membership grow their practices in an era of declining reimbursements. Publications include “Healthcare 2020”—a perspective on the key trends shaping the global healthcare market and “Opportunities in integrated care for pharma and biotech.” Mr. Eliades graduated magna cum laude with highest honors from Harvard College where he received a Bachelor of Arts. He also holds a Master of Arts and PhD from Harvard University.


Nick DeVito is the President of Nicholas DeVito Agency, an independent insurance agency in Long Island, New York that specializes in all personal and commercial insurance coverages for individuals and businesses within the tristate area. Nick is also one of the cofounders of the Pete DeVito Memorial Foundation (PDMF), which he helped establish in 2011 shortly after his father Pete passed away from IPF. From diagnosis to his father’s last days, Nick saw first-hand the impact IPF has on a family.  Since founding the PDMF, Nick has been an active advocate raising over half a million dollars toward IPF medical research, public awareness, and advocacy. Nick has supported and worked closely with the PFF for years, and is proud to now join its board of directors. Nick holds a Bachelor of Arts in Political Science from Quinnipiac University and a Master of Science in Counseling from Long Island University Post.

Naftali kaminski, md

Naftali Kaminski, MD is the Boehringer Ingelheim Endowed Professor of Medicine and Chief of Pulmonary, Critical Care and Sleep Medicine at Yale School of Medicine. Dr. Kaminski’s achievements and contributions have been widely recognized in recent years. In 2016, Dr. Kaminski was elected a fellow of the European Respiratory Society (ERS) and was awarded the ERS Gold Medal in Interstitial Lung Disease. He received the American Thoracic Society Recognition Award for Scientific Accomplishments and the Helmholtz International Fellow Award in 2013. Before joining Yale, Dr. Kaminski served as the founding director of the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease at the University of Pittsburgh Medical Center, which he led to national prominence. As chief of Pulmonary, Critical Care and Sleep Medicine at Yale, he led the section through an unprecedented period of growth including junior faculty retention and promotion, significant growth of all clinical programs, doubling of research funding, and the creation and reorganization of novel centers of excellence. Dr. Kaminski is passionate about training physician-scientists for the challenges of 21st-century medicine. He is also a strong advocate for breaking barriers between patients, their families, and health care systems and empowering patients to become stakeholders in research, medical management, and health care policy.

daniel m. rose, md

Daniel M. Rose, MD has been involved with the foundation since its inception in September 2000. Dr. Rose served as Chairman of the Board of Directors from 2002 until June 2014, when Board Vice Chairman Michael Henderson assumed the chairmanship. Dr. Rose received a BA from Wesleyan University in Middletown, CT in 1969, and a MD from the University of Colorado in 1974. He did a general surgical residency and cardiothoracic surgical residency at NYU/Bellevue hospitals from 1974-82. He also did research at the NIH in 1979-80. Prior to becoming President of the Foundation, Dr. Rose had been a practicing cardiothoracic surgeon and had been Chief of Cardiothoracic Surgery for 19 years at St. Vincent’s Medical Center in Bridgeport, CT.

stephen a. wald, phd

Stephen A. Wald, PhD, was raised in Salem, Ohio, and graduated from Cornell University with a bachelor’s and a PhD from the School of Chemical Engineering. He served as Captain in the US Army, has been a corporate President and founder of several entrepreneurial businesses. Since 2003, Dr. Wald has served as an advocate of a new Center for PF Treatment & Translational Research in the pacific northwest. He is married with two sons and five grandchildren. His hobbies include writing, fitness, mycology (wild mushroom hunting), mentoring, boating. Dr. Wald was diagnosed with pulmonary fibrosis in 1998, and has been treated since at the University of Washington Medical Center by the Physician-Scientist Ganesh Raghu, MD.

Members Emeriti

Retiring members of the PFF Board of Directors who have made exceptional contributions to the Foundation are honored with the status "Member Emeritus."  

Joseph Borus, Esq.
Thomas E. Hales 

footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >